Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1991-12-04
1993-03-23
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
514 12, 514 13, 514 21, 514558, 12866001, 12866202, 530363, 530427, 424 2, A61K 4900, A61B 812
Patent
active
051961830
ABSTRACT:
Particles having an average diameter of less than about 12 microns comprising fatty acid cores encapsulated with human serum albumin and methods for their preparation are disclosed. These materials are useful as contrast agents in ultrasonic imaging, having scattering intensities that are equivalent to or greater than those obtain from dispersed microbubbles but being much more stable, both in storage and when used in vivo, than are contrast agents based on dispersed microbubbles.
REFERENCES:
patent: 4572203 (1986-02-01), Feinstein
patent: 4718433 (1988-01-01), Feinstein
patent: 4774958 (1988-10-01), Feinstein
patent: 4832941 (1989-05-01), Berwing et al.
patent: 4844882 (1989-07-01), Widder et al.
patent: 4957656 (1990-09-01), Cerny et al.
Power Susan E.
Yudelson Joseph S.
Davis William J.
Hollrah Glennon H.
Newman Irving
Russell Mark W.
Sterling Winthrop Inc.
LandOfFree
Contrast agents for ultrasound imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Contrast agents for ultrasound imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Contrast agents for ultrasound imaging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1350233